KaLy-Cell was founded in 2004 by Prof Lysiane Richert, Ph.D. to provide contract research services with hepatocytes to optimize the discovery, development and approval of drugs, food additives, agrochemicals and nutraceuticals.
KaLy-Cell services deliver informations to evaluate inter-species differences and to predict inter-individual variations in safety and drug efficacy, and to explain adverse reactions.